LOC283267 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.993000E-01
Normal-vs-Stage2
9.245000E-01
Normal-vs-Stage3
2.594600E-01
Normal-vs-Stage4
7.378400E-01
Stage1-vs-Stage2
5.304400E-01
Stage1-vs-Stage3
3.260800E-01
Stage1-vs-Stage4
5.427400E-01
Stage2-vs-Stage3
3.108600E-01
Stage2-vs-Stage4
6.543000E-01
Stage3-vs-Stage4
5.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.616800E-01
Normal-vs-AfricanAmerican
7.073000E-01
Normal-vs-Asian
7.268400E-01
Caucasian-vs-AfricanAmerican
7.299600E-01
Caucasian-vs-Asian
4.006600E-01
AfricanAmerican-vs-Asian
3.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.617200E-01
Normal-vs-Female
4.398200E-01
Male-vs-Female
5.426600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.111200E-01
Normal-vs-Age(41-60Yrs)
5.005000E-01
Normal-vs-Age(61-80Yrs)
6.459800E-01
Normal-vs-Age(81-100Yrs)
7.110600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.250800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.500200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.399000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.283930E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.109370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.535000E-01
Normal-vs-Daily Drinker
3.968400E-01
Normal-vs-Weekly Drinker
9.719800E-01
Normal-vs-Occasional Drinker
4.511400E-01
Normal-vs-Social Drinker
5.095800E-02
Non Drinker-vs-Daily Drinker
3.089600E-01
Non Drinker-vs-Weekly Drinker
7.207600E-01
Non Drinker-vs-Occasional Drinker
3.280000E-01
Non Drinker-vs-Social Drinker
2.946100E-02
Daily Drinker-vs-Weekly Drinker
1.648410E-01
Daily Drinker-vs-Occasional Drinker
8.496400E-02
Daily Drinker-vs-Social Drinker
6.938500E-03
Weekly Drinker-vs-Occasional Drinker
5.797200E-01
Weekly Drinker-vs-Social Drinker
9.668300E-02
Occasional Drinker-vs-Social Drinker
2.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.477800E-01
Normal-vs-Grade 2
1.675380E-01
Normal-vs-Grade 3
2.118600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.522400E-01
Grade 1-vs-Grade 3
6.240800E-01
Grade 1-vs-Grade 4
3.477800E-01
Grade 2-vs-Grade 3
5.831200E-01
Grade 2-vs-Grade 4
1.675380E-01
Grade 3-vs-Grade 4
2.118600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.431800E-01
Normal-vs-NonDiabetic
9.015800E-01
Diabetic-vs-NonDiabetic
3.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.445400E-01
Normal-vs-NoPancreatitis
9.942200E-01
Pancreatitis-vs-NoPancreatitis
5.871800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.537600E-01
Normal-vs-N1
9.411400E-01
N0-vs-N1
5.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.083800E-01
Normal-vs-TP53-NonMutant
2.900500E-02
TP53-Mutant-vs-TP53-NonMutant
2.681000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
